Competitors of Torrent Pharmaceuticals Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,763 Cr. | 345 | 390/108 | 68.8 | 18.5 | 0.19 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 65.9 Cr. | 88.8 | 88.8/19.6 | 45.1 | 9.58 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 27.2 Cr. | 18.6 | 18.8/7.60 | 160 | 5.00 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 93.2 Cr. | 124 | 155/82.1 | 14.5 | 51.8 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 14,114 Cr. | 1,152 | 1,335/609 | 31.6 | 190 | 1.95 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 494 Cr. | 21.7 | 29.0/9.75 | 33.0 | 7.24 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.61 Cr. | 15.7 | 28.5/10.0 | 152 | 13.3 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 376 Cr. | 801 | 1,054/650 | 21.7 | 255 | 0.09 % | 17.6 % | 15.0 % | 10.0 |
| Fervent Synergies Ltd | 53.9 Cr. | 18.0 | 27.8/14.6 | 10.1 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 857 Cr. | 291 | 332/144 | 98.2 | 0.43 % | 3.20 % | 5.59 % | 5.00 | |
| Fabino Enterprises Ltd | 5.63 Cr. | 26.8 | 43.8/23.6 | 113 | 19.8 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 20.7 Cr. | 8.30 | 19.4/8.20 | 45.9 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 108 Cr. | 135 | 184/110 | 49.7 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 32.9 Cr. | 1.33 | 3.10/0.95 | 2.26 | 0.00 % | 0.79 % | 0.13 % | 2.00 | |
| Dipna Pharmachem Ltd | 18.4 Cr. | 7.67 | 16.6/7.00 | 16.9 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 16.5 Cr. | 16.4 | 25.8/14.4 | 75.1 | 21.6 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 301 Cr. | 844 | 999/262 | 13.2 | 497 | 0.24 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 36.9 Cr. | 36.9 | 61.5/30.1 | 33.8 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 26.1 Cr. | 57.2 | 84.4/35.2 | 51.2 | 19.6 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 12.6 Cr. | 5.06 | 26.5/5.06 | 50.6 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 9.90 Cr. | 66.0 | 87.0/28.0 | 9.17 | 85.3 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.90 Cr. | 14.4 | 14.4/4.09 | 71.8 | 0.97 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 51.5 Cr. | 68.2 | 160/63.0 | 33.7 | 38.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.22 Cr. | 20.7 | 27.8/14.6 | 16.9 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 118 Cr. | 27.4 | 43.9/22.5 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 21.3 Cr. | 41.9 | 45.0/19.4 | 35.4 | 17.6 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 188 Cr. | 326 | 408/162 | 19.1 | 108 | 1.38 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 18.0 Cr. | 30.6 | 30.6/4.68 | 2.07 | 0.00 % | 13.1 % | 13.8 % | 10.0 | |
| Aurobindo Pharma Ltd | 85,902 Cr. | 1,466 | 1,593/835 | 24.0 | 509 | 0.31 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 139 Cr. | 222 | 307/105 | 17.8 | 67.3 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,014 Cr. | 202 | 265/124 | 17.5 | 58.1 | 1.24 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 65.8 Cr. | 50.4 | 86.1/44.5 | 59.0 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 6,860 Cr. | 1,677 | 1,823/1,004 | 108 | 183 | 0.18 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 5.29 Cr. | 0.80 | 0.93/0.54 | 0.81 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 433 Cr. | 56.6 | 77.7/35.3 | 36.8 | 17.9 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 11.7 Cr. | 20.0 | 29.0/11.9 | 2.92 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 85.0 Cr. | 50.5 | 60.8/40.2 | 149 | 18.3 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 59,722 Cr. | 28,105 | 30,521/21,907 | 48.2 | 1,741 | 1.46 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,629 Cr. | 621 | 722/371 | 25.0 | 194 | 0.48 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 168 Cr. | 66.3 | 75.8/37.0 | 25.8 | 51.3 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,571 Cr. | 592 | 725/372 | 34.8 | 0.17 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 14,812 Cr. | 966 | 1,099/213 | 219 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 831 Cr. | 254 | 291/73.7 | 30.8 | 6.70 | 0.00 % | 62.5 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 21.3 | 0.00 % | 51.5 % | 163 % | 2.00 | |
| Venus Remedies Ltd | 437 Cr. | 327 | 430/225 | 15.3 | 365 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 4,472 Cr. | 635 | 700/399 | 336 | 0.00 % | 0.39 % | 1.17 % | 2.00 | |
| TTK Healthcare Ltd | 2,277 Cr. | 1,612 | 1,923/1,101 | 35.9 | 708 | 0.62 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,17,555 Cr. | 3,474 | 3,574/1,823 | 70.3 | 203 | 0.81 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,497 Cr. | 271 | 304/142 | 49.9 | 41.0 | 0.18 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,961 Cr. | 20.9 | 27.9/7.25 | 72.5 | 3.05 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 30,544 Cr. | 1,200 | 1,289/541 | 127 | 80.6 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 3,100 Cr. | 142 | 169/60.8 | 12.4 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,58,285 Cr. | 1,910 | 1,960/1,068 | 43.5 | 265 | 0.71 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,732 Cr. | 759 | 830/264 | 195 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 3,082 Cr. | 364 | 398/112 | 54.6 | 64.0 | 0.11 % | 11.4 % | 9.53 % | 1.00 |
| SMS Lifesciences India Ltd | 441 Cr. | 1,459 | 1,750/464 | 26.6 | 585 | 0.10 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,846 Cr. | 802 | 960/296 | 191 | 208 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 5,174 Cr. | 207 | 241/90.7 | 242 | 26.3 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 15,816 Cr. | 6,867 | 7,600/4,434 | 32.2 | 298 | 2.43 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 4,315 Cr. | 2,609 | 2,650/1,210 | 46.7 | 227 | 0.61 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,845 Cr. | 5,328 | 5,643/4,637 | 41.1 | 324 | 0.94 % | 44.9 % | 33.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 141 Cr. | 40.0 | 79.2/35.4 | 20.4 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 25,694 Cr. | 5,616 | 6,453/3,834 | 42.6 | 786 | 0.62 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 290 Cr. | 236 | 325/190 | 19.9 | 69.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 1,882 Cr. | 307 | 367/112 | 137 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 6,513 Cr. | 1,284 | 1,592/432 | 58.4 | 231 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 15,495 Cr. | 12,077 | 13,630/3,611 | 48.3 | 1,000 | 0.12 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 941 Cr. | 41.9 | 56.5/21.2 | 153 | 47.7 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,251 Cr. | 1,354 | 1,639/724 | 14.8 | 327 | 0.70 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,625 Cr. | 84.4 | 101/31.3 | 39.3 | 16.6 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,133 Cr. | 290 | 329/97.4 | 39.4 | 45.6 | 0.21 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 194 Cr. | 123 | 145/85.2 | 61.3 | 89.9 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 467 Cr. | 131 | 173/97.9 | 507 | 17.9 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 1,00,272 Cr. | 2,198 | 2,312/1,113 | 44.3 | 314 | 0.36 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,328 Cr. | 663 | 814/471 | 13.6 | 296 | 0.27 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 24,001 Cr. | 445 | 518/349 | 100 | 78.1 | 0.18 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 796 Cr. | 767 | 865/309 | 24.7 | 218 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 170 Cr. | 79.0 | 122/60.0 | 55.3 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,511 Cr. | 313 | 370/185 | 25.5 | 102 | 0.96 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 539 Cr. | 335 | 470/248 | 52.9 | 110 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 17,713 Cr. | 1,112 | 1,247/319 | 75.7 | 341 | 0.45 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,639 Cr. | 1,715 | 2,030/1,244 | 45.4 | 188 | 0.71 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,156 Cr. | 437 | 460/270 | 50.8 | 70.9 | 1.15 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 37,837 Cr. | 1,491 | 1,528/924 | 71.4 | 250 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,651 Cr. | 452 | 538/331 | 22.3 | 274 | 1.11 % | 12.3 % | 8.68 % | 10.0 |
| Glenmark Pharmaceuticals Ltd | 46,919 Cr. | 1,663 | 1,774/702 | 278 | 0.15 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 46,610 Cr. | 2,751 | 3,088/1,385 | 60.5 | 105 | 1.16 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,10,694 Cr. | 6,633 | 7,107/5,206 | 19.9 | 1,694 | 0.60 % | 26.5 % | 21.4 % | 5.00 |
| Dishman Carbogen Amcis Ltd | 2,738 Cr. | 175 | 283/133 | 359 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,31,092 Cr. | 1,623 | 1,685/1,132 | 29.6 | 331 | 0.80 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,969 Cr. | 1,969 | 2,159/950 | 31.4 | 276 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 388 Cr. | 148 | 186/72.5 | 25.0 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,370 Cr. | 130 | 150/77.4 | 12.9 | 92.4 | 0.38 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 127 Cr. | 78.0 | 92.0/42.6 | 201 | 11.2 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 41,583 Cr. | 346 | 396/218 | 26.6 | 165 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,559 Cr. | 1,621 | 1,985/892 | 42.8 | 163 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 209 Cr. | 131 | 158/81.2 | 27.8 | 43.4 | 0.91 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 199 Cr. | 84.3 | 113/73.2 | 317 | 34.2 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 18,592 Cr. | 7,437 | 8,140/4,050 | 142 | 285 | 0.32 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,222 Cr. | 769 | 863/556 | 52.2 | 99.8 | 0.60 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 264 Cr. | 126 | 145/69.6 | 14.0 | 77.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 74,060 Cr. | 6,194 | 6,440/3,490 | 34.6 | 862 | 0.65 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 24,430 Cr. | 1,243 | 1,286/707 | 38.8 | 245 | 0.89 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 843 Cr. | 1,476 | 1,754/791 | 11.9 | 671 | 0.78 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 41,530 Cr. | 3,325 | 3,486/1,650 | 48.6 | 283 | 1.08 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 5,505 Cr. | 492 | 571/291 | 37.1 | 118 | 1.04 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,747 Cr. | 516 | 635/430 | 36.7 | 128 | 0.19 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 21,032.14 Cr | 1,273.08 | 62.97 | 187.12 | 0.29% | 16.84% | 16.00% | 6.69 |
